Understanding how drug delivery systems distribute in vivo remains a major challenge in developing nanomedicines. Especially ...

BioNTech continued to grow its oncology business by agreeing to buy fellow German biotech CureVac for $1.25 billion in a deal that combines two of the world's leaders in mRNA treatments.

BioNTech continued to grow its oncology business by agreeing to buy fellow German biotech CureVac for $1.25 billion in a deal ...

Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that transports genetic therapies ...

A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to ...

A positive effect that COVID-19 vaccines would have on the human body has been discovered. The technology used in these vaccines could also lead scientists to a cure for the human ...

The global pharmaceutical lipids market is valued at USD 5.4 billion in 2025, registering Y-o-Y growth of 5.1% attaining market value of USD 9.0 billion by 2035. The revenue generated by allergy ...

The quickly evolving development of biopharmaceuticals is impacting innovation in the industry overall.

Find more information on the Altmetric Attention Score and how the score is calculated. Lipid–albumin nanoparticles (LAN) were synthesized for delivery of RX-0047, an antisense oligonucleotide (ASO) ...

SNS Insider Unveils Strategic Insights into the U.S. Lipid Nanoparticles Market's Rapid Growth—Valued at USD 333.94 Million in 2023—As the U.S. Leads More Than 38% of Global Share Amid Explosive ...

School of Integrative Engineering, Chung-Ang University, Seoul 06974, Republic of Korea Feynman Institute of Technology, Nanomedicine Corporation, Seoul 06974, Republic of Korea ...